Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

9.9K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.9K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.6K
3.6K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

18.6K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.6K
piRNA - Piwi-interacting RNAs02:57

piRNA - Piwi-interacting RNAs

7.6K
PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
7.6K
Nursing Code of Ethics01:29

Nursing Code of Ethics

4.5K
The Nursing Code of Ethics sets the ethical benchmark for the profession, and guides nurses in ethical analysis and decision making at the societal, organizational, and clinical levels. The code encompasses showing compassion and respect for the patient, their families, and communities in all circumstances while committing to providing patient-centered care. In addition, the code states that nurses must advocate for the patient by defending a cause or recommendation to protect their rights,...
4.5K
Small interfering RNAs (siRNA)02:30

Small interfering RNAs (siRNA)

4.5K
4.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Type 2 diabetes and glycemic traits are not causal factors of delirium: A two-sample mendelian randomization analysis.

Frontiers in genetics·2023
Same author

The Analgesic Efficacy of Intraperitoneal Ropivacaine Versus Bupivacaine for Laparoscopic Cholecystectomy: a Meta-Analysis.

Zentralblatt fur Chirurgie·2022
Same author

Diagnostic Value of Multimodal Intraoperative Neuromonitoring by Combining Somatosensory-With Motor-Evoked Potential in Posterior Decompression Surgery for Thoracic Spinal Stenosis.

Frontiers in neuroscience·2022
Same author

A Loading Dose of Dexmedetomidine With Constant Infusion Inhibits Intraoperative Neuromonitoring During Thoracic Spinal Decompression Surgery: A Randomized Prospective Study.

Frontiers in pharmacology·2022
Same author

Improvement of cardiac function after coronary artery bypass grafting surgery reduces the risk of postoperative acute kidney injury.

Clinical cardiology·2022
Same author

Hypertrophic obstructive cardiomyopathy with a basal septal thickness of 16 mm or less: clinical characteristics and surgical results.

Surgery today·2022
Same journal

Mortality trends and projections for type 2 diabetes with concomitant Parkinson's versus Alzheimer's disease among older United States adults, 1999-2023: A retrospective cohort study.

Medicine·2026
Same journal

The causal relationship between the palmitoylation gene ZDHHC13 and ulcerative colitis: A Mendelian randomization study implicating CD62L-monocyte AC.

Medicine·2026
Same journal

Intraoperative outcomes of 2-dose indocyanine green fluorescence imaging strategies versus white light in laparoscopic cholecystectomy for cystic duct stones: A retrospective comparative study.

Medicine·2026
Same journal

Development and internal validation of a risk prediction model for gastric precancerous lesions integrating Helicobacter pylori serologic typing and host susceptibility polymorphisms.

Medicine·2026
Same journal

Causal effects of circulating inflammatory proteins on COPD: A Mendelian randomization study.

Medicine·2026
Same journal

Laparoscopic duodenojejunostomy for recurrent acute pancreatitis associated with superior mesenteric artery syndrome in a medically complex patient: A case report and literature review.

Medicine·2026
See all related articles

Related Experiment Video

Updated: Jan 29, 2026

Author Spotlight: RNA FISH for Locating lncRNA-SNHG6 in Osteosarcoma Cells
05:27

Author Spotlight: RNA FISH for Locating lncRNA-SNHG6 in Osteosarcoma Cells

Published on: June 16, 2023

2.3K

Integrative analysis reveals driver long non-coding RNAs in osteosarcoma.

Zhenguo Luo1,2, Li Xiao2, Jing Li3

  • 1Department of Orthopedics, The Second Affiliated Hospital of Xi'an Jiaotong University.

Medicine
|February 9, 2019
PubMed
Summary
This summary is machine-generated.

This study identifies novel long non-coding RNAs (lncRNAs) driving osteosarcoma (OS) development by analyzing copy number alterations and gene expression. One lncRNA, RP11-241F15.10, acts as a tumor suppressor, potentially offering new therapeutic targets for OS.

More Related Videos

Cell Based Assays of SINEUP Non-coding RNAs That Can Specifically Enhance mRNA Translation
10:21

Cell Based Assays of SINEUP Non-coding RNAs That Can Specifically Enhance mRNA Translation

Published on: February 1, 2019

8.8K
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

1.2K

Related Experiment Videos

Last Updated: Jan 29, 2026

Author Spotlight: RNA FISH for Locating lncRNA-SNHG6 in Osteosarcoma Cells
05:27

Author Spotlight: RNA FISH for Locating lncRNA-SNHG6 in Osteosarcoma Cells

Published on: June 16, 2023

2.3K
Cell Based Assays of SINEUP Non-coding RNAs That Can Specifically Enhance mRNA Translation
10:21

Cell Based Assays of SINEUP Non-coding RNAs That Can Specifically Enhance mRNA Translation

Published on: February 1, 2019

8.8K
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

1.2K

Area of Science:

  • Genomics
  • Molecular Biology
  • Oncology

Background:

  • Osteosarcoma (OS) research has identified protein-coding driver genes, but the role of long non-coding RNAs (lncRNAs) remains underexplored.
  • Discovering driver lncRNAs is crucial for understanding OS pathogenesis and developing targeted therapies.

Purpose of the Study:

  • To identify novel driver long non-coding RNAs (lncRNAs) in osteosarcoma (OS) using integrated genomic and transcriptomic data.
  • To investigate the functional role of identified lncRNAs in OS development and their potential as therapeutic targets.

Main Methods:

  • Collected somatic copy number alteration (SCNA) and gene expression profiles from 84 OS samples via the TARGET project.
  • Analyzed RNA sequencing data to detect expressed lncRNAs and SNP array data for SCNAs.
  • Performed integrative analysis of SCNA and gene expression data to identify driver genes, including novel lncRNAs.

Main Results:

  • Identified 13,903 expressed lncRNAs, with 167 driver genes including 162 novel lncRNAs.
  • Detected significant SCNAs, including amplifications and deletions across multiple chromosomes.
  • RP11-241F15.10 identified as a potential tumor suppressor lncRNA, with its loss potentially activating the Wnt signaling pathway.

Conclusions:

  • This study enhances understanding of the roles of lncRNAs in osteosarcoma (OS), distinguishing between oncogenic and tumor-suppressive functions.
  • Identified novel lncRNAs, including RP11-241F15.10, provide potential therapeutic avenues for metastatic or relapsed OS patients.